Ask Warren

Pharmicell

005690 · KOSPI · ₩005690 · 파미셀

₩9,800▼ ₩430 (4.20%)End-of-day · Oct 29, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩39B₩37B₩35B₩26B₩27B₩27B₩21B₩15B
Cost of sales₩22B₩19B₩20B₩14B₩15B₩14B₩13B₩9.5B
Gross profit₩17B₩17B₩14B₩12B₩12B₩13B₩8.1B₩5.1B
Operating income₩13B₩13B₩9.6B₩8.1B₩8.2B₩8.4B₩3.1B₩1.3B
Net income−₩1.3B₩12B₩32B₩1.4B−₩1.1B₩8.5B₩5.6B−₩2.1B
Net income to shareholders−₩1.3B₩12B₩32B₩1.4B−₩1.1B₩8.5B₩5.6B−₩2.1B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩184B₩168B₩157B₩130B₩121B₩106B₩99B₩92B
Current assets₩115B₩108B₩95B₩77B₩71B₩55B₩48B₩40B
Cash and equivalents₩15B₩23B₩29B₩19B₩29B₩7B₩8.3B₩10B
Total liabilities₩41B₩35B₩33B₩20B₩20B₩12B₩13B₩9.2B
Current liabilities₩16B₩16B₩20B₩7.1B₩7.2B₩7.3B₩7.6B₩4.4B
Borrowings₩25B₩20B₩14B₩1.3B₩8B₩526M₩317M₩141M
Total equity₩143B₩133B₩124B₩110B₩101B₩94B₩86B₩83B
Shareholders' equity₩143B₩133B₩124B₩110B₩101B₩94B₩86B₩83B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations₩16B−₩1.5B₩17B₩8.8B₩16B−₩1B₩95M₩5.9B
Capital spending₩6.5B₩1.3B₩6.5B₩622M₩249M₩89M₩134M₩467M
Free cash flow₩9.9B−₩2.7B₩11B₩8.2B₩16B−₩1.1B−₩39M₩5.4B

Consolidated where available. Amounts in won.

Also known as: Pharmicell / 파미셀 / 005690 / KRX:005690

Source: KRX statistical information